PKD1 c.9829C>T ;(p.R3277C)

Variant ID: 16-2149956-G-A

NM_001009944.2(PKD1):c.9829C>T;(p.R3277C)

This variant was identified in 66 publications

View GRCh38 version.




Publications:


Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease.

Physiological Reports
Arkhipov, Sergey N SN; Potter, D'Anna L DL; Sultanova, Regina F RF; Ilatovskaya, Daria V DV; Harris, Peter C PC; Pavlov, Tengis S TS
Publication Date: 2023-04

Variant appearance in text: PKD1: Arg3277Cys
PubMed Link: 37024297
Variant Present in the following documents:
  • Main text
  • PHY2-11-e15652.pdf
View BVdb publication page



Review of the Use of Animal Models of Human Polycystic Kidney Disease for the Evaluation of Experimental Therapeutic Modalities.

Journal Of Clinical Medicine
Nagao, Shizuko S; Yamaguchi, Tamio T
Publication Date: 2023-01-14

Variant appearance in text: PKD1: R3277C
PubMed Link: 36675597
Variant Present in the following documents:
  • Main text
  • jcm-12-00668.pdf
View BVdb publication page



Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease.

Nature Communications
Li, Sienna R SR; Gulieva, Ramila E RE; Helms, Louisa L; Cruz, Nelly M NM; Vincent, Thomas T; Fu, Hongxia H; Himmelfarb, Jonathan J; Freedman, Benjamin S BS
Publication Date: 2022-12-23

Variant appearance in text: PKD1: R3277C
PubMed Link: 36564419
Variant Present in the following documents:
  • Main text
  • 41467_2022_Article_35537.pdf
View BVdb publication page



Caspase-1 and the inflammasome promote polycystic kidney disease progression.

Frontiers In Molecular Biosciences
Swenson-Fields, Katherine I KI; Ward, Christopher J CJ; Lopez, Micaila E ME; Fross, Shaneann S; Heimes Dillon, Anna L AL; Meisenheimer, James D JD; Rabbani, Adib J AJ; Wedlock, Emily E; Basu, Malay K MK; Jansson, Kyle P KP; Rowe, Peter S PS; Stubbs, Jason R JR; Wallace, Darren P DP; Vitek, Michael P MP; Fields, Timothy A TA
Publication Date: 2022

Variant appearance in text: PKD1: R3277C
PubMed Link: 36523654
Variant Present in the following documents:
  • Main text
  • fmolb-09-971219.pdf
View BVdb publication page



The tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression.

Jci Insight
Nguyen, Dustin T DT; Kleczko, Emily K EK; Dwivedi, Nidhi N; Monaghan, Marie-Louise T MT; Gitomer, Berenice Y BY; Chonchol, Michel B MB; Clambey, Eric T ET; Nemenoff, Raphael A RA; Klawitter, Jelena J; Hopp, Katharina K
Publication Date: 2022-11-24

Variant appearance in text: PKD1: R3277C
PubMed Link: 36422996
Variant Present in the following documents:
  • jciinsight-8-154773.pdf
View BVdb publication page



Kidney Cyst Lining Epithelial Cells Are Resistant to Low-Dose Cisplatin-Induced DNA Damage in a Preclinical Model of Autosomal Dominant Polycystic Kidney Disease.

International Journal Of Molecular Sciences
Saravanabavan, Sayanthooran S; Rangan, Gopala K GK
Publication Date: 2022-10-19

Variant appearance in text: PKD1: R3277C
PubMed Link: 36293397
Variant Present in the following documents:
  • Main text
  • ijms-23-12547.pdf
View BVdb publication page



Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease.

Frontiers In Molecular Biosciences
Iliuta, Ioan-Andrei IA; Song, Xuewen X; Pickel, Lauren L; Haghighi, Amirreza A; Retnakaran, Ravi R; Scholey, James J; Sung, Hoon-Ki HK; Steinberg, Gregory R GR; Pei, York Y
Publication Date: 2022

Variant appearance in text: PKD1: R3277C
PubMed Link: 36106024
Variant Present in the following documents:
  • Main text
  • fmolb-09-962933.pdf
View BVdb publication page



Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease.

Drugs
Bais, Thomas T; Gansevoort, Ron T RT; Meijer, Esther E
Publication Date: 2022-07

Variant appearance in text: PKD1: R3277C
PubMed Link: 35852784
Variant Present in the following documents:
  • 40265_2022_Article_1745.pdf
View BVdb publication page



Are transient protein-protein interactions more dispensable?

Plos Computational Biology
Ghadie, Mohamed Ali MA; Xia, Yu Y
Publication Date: 2022-04

Variant appearance in text: PKD1: 9829C>T; Arg3277Cys
PubMed Link: 35404956
Variant Present in the following documents:
  • pcbi.1010013.s002.xlsx, sheet 4
View BVdb publication page



c-JUN n-Terminal Kinase (JNK) Signaling in Autosomal Dominant Polycystic Kidney Disease.

Journal Of Cellular Signaling
Smith, Abigail O AO; Jonassen, Julie A JA; Preval, Kenley M KM; Davis, Roger J RJ; Pazour, Gregory J GJ
Publication Date: 2022

Variant appearance in text: PKD1: R3277C
PubMed Link: 35253003
Variant Present in the following documents:
  • Main text
  • nihms-1780319.pdf
View BVdb publication page



Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease.

Clinical Kidney Journal
Nielsen, Marlene L ML; Mundt, Mia C MC; Lildballe, Dorte L DL; Rasmussen, Maria M; Sunde, Lone L; Torres, Vicente E VE; Harris, Peter C PC; Birn, Henrik H
Publication Date: 2021-11

Variant appearance in text: PKD1: R3277C
PubMed Link: 34754438
Variant Present in the following documents:
  • Main text
  • sfab088.pdf
View BVdb publication page



Is There a Functional Role of Mitochondrial Dysfunction in the Pathogenesis of ARPKD?

Frontiers In Medicine
Liebau, Max Christoph MC
Publication Date: 2021

Variant appearance in text: PKD1: Arg3277Cys
PubMed Link: 34676227
Variant Present in the following documents:
  • Main text
  • fmed-08-739534.pdf
View BVdb publication page



Metabolic derangement in polycystic kidney disease mouse models is ameliorated by mitochondrial-targeted antioxidants.

Communications Biology
Daneshgar, Nastaran N; Baguley, Andrew W AW; Liang, Peir-In PI; Wu, Fei F; Chu, Yi Y; Kinter, Michael T MT; Benavides, Gloria A GA; Johnson, Michelle S MS; Darley-Usmar, Victor V; Zhang, Jianhua J; Chan, Kung-Sik KS; Dai, Dao-Fu DF
Publication Date: 2021-10-20

Variant appearance in text: PKD1: R3277C
PubMed Link: 34671066
Variant Present in the following documents:
  • Main text
View BVdb publication page



Replacing the SpCas9 HNH domain by deaminases generates compact base editors with an alternative targeting scope.

Molecular Therapy. Nucleic Acids
Villiger, Lukas L; Schmidheini, Lukas L; Mathis, Nicolas N; Rothgangl, Tanja T; Marquart, Kim K; Schwank, Gerald G
Publication Date: 2021-12-03

Variant appearance in text: PKD1: 9829C>T; Arg3277Cys
PubMed Link: 34631280
Variant Present in the following documents:
  • mmc3.xlsx, sheet 1
View BVdb publication page



Pre-clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease.

Faseb Journal : Official Publication Of The Federation Of American Societies For Experimental Biology
Di Mise, Annarita A; Wang, Xiaofang X; Ye, Hong H; Pellegrini, Lorenzo L; Torres, Vicente E VE; Valenti, Giovanna G
Publication Date: 2021-10

Variant appearance in text: PKD1: R3277C
PubMed Link: 34486176
Variant Present in the following documents:
  • Main text
  • FSB2-35-0.pdf
View BVdb publication page



Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease.

Kidney International Reports
Janssens, Peter P; Decuypere, Jean-Paul JP; De Rechter, Stéphanie S; Breysem, Luc L; Van Giel, Dorien D; Billen, Jaak J; Hindryckx, An A; De Catte, Luc L; Baldewijns, Marcella M; Claes, Kathleen B M KBM; Wissing, Karl M KM; Devriendt, Koen K; Bammens, Bert B; Meyts, Isabelle I; Torres, Vicente E VE; Vennekens, Rudi R; Mekahli, Djalila D
Publication Date: 2021-06

Variant appearance in text: PKD1: 9829C>T; Arg3277Cys
PubMed Link: 34169210
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Long-term dietary nitrate supplementation does not reduce renal cyst growth in experimental autosomal dominant polycystic kidney disease.

Plos One
Zhang, Jennifer Q J JQJ; Saravanabavan, Sayanthooran S; Cheng, Kai Man KM; Raghubanshi, Aarya A; Chandra, Ashley N AN; Munt, Alexandra A; Rayner, Benjamin B; Zhang, Yunjia Y; Chau, Katrina K; Wong, Annette T Y ATY; Rangan, Gopala K GK
Publication Date: 2021

Variant appearance in text: PKD1: R3277C
PubMed Link: 33886581
Variant Present in the following documents:
  • Main text
View BVdb publication page



Non-Coding RNAs in Hereditary Kidney Disorders.

International Journal Of Molecular Sciences
Zhou, Julie Xia JX; Li, Xiaogang X
Publication Date: 2021-03-16

Variant appearance in text: PKD1: R3277C
PubMed Link: 33809516
Variant Present in the following documents:
  • Main text
View BVdb publication page



Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease.

Cells
Zhang, Jennifer Q J JQJ; Saravanabavan, Sayanthooran S; Rangan, Gopala K GK
Publication Date: 2021-03-03

Variant appearance in text: PKD1: R3277C
PubMed Link: 33802342
Variant Present in the following documents:
  • Main text
  • cells-10-00532.pdf
View BVdb publication page



MicroRNAs and Polycystic Kidney Disease.

Kidney Medicine
Li, Dantong D; Sun, Liangzhong L
Publication Date: 2020

Variant appearance in text: PKD1: R3277C
PubMed Link: 33319200
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Clinical impact of genomic testing in patients with suspected monogenic kidney disease.

Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Jayasinghe, Kushani K; Stark, Zornitza Z; Kerr, Peter G PG; Gaff, Clara C; Martyn, Melissa M; Whitlam, John J; Creighton, Belinda B; Donaldson, Elizabeth E; Hunter, Matthew M; Jarmolowicz, Anna A; Johnstone, Lilian L; Krzesinski, Emma E; Lunke, Sebastian S; Lynch, Elly E; Nicholls, Kathleen K; Patel, Chirag C; Prawer, Yael Y; Ryan, Jessica J; See, Emily J EJ; Talbot, Andrew A; Trainer, Alison A; Tytherleigh, Rigan R; Valente, Giulia G; Wallis, Mathew M; Wardrop, Louise L; West, Kirsty H KH; White, Susan M SM; Wilkins, Ella E; Mallett, Andrew J AJ; Quinlan, Catherine C
Publication Date: 2021-01

Variant appearance in text: PKD1: 9829C>T; Arg3277Cys
PubMed Link: 32939031
Variant Present in the following documents:
  • 41436_2020_963_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Reconsidering Genetic Testing for Neonatal Polycystic Kidney Disease.

Kidney International Reports
VanNoy, Grace E GE; Wojcik, Monica H MH; Genetti, Casie A CA; Mullen, Thomas E TE; Agrawal, Pankaj B PB; Stein, Deborah R DR
Publication Date: 2020-08

Variant appearance in text: PKD1: R3277C
PubMed Link: 32775833
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs.

International Journal Of Molecular Sciences
Koslowski, Svenja S; Latapy, Camille C; Auvray, Pierrïck P; Blondel, Marc M; Meijer, Laurent L
Publication Date: 2020-06-25

Variant appearance in text: PKD1: R3277C
PubMed Link: 32630605
Variant Present in the following documents:
  • Main text
View BVdb publication page



Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families.

Frontiers In Genetics
Mantovani, Vilma V; Bin, Sofia S; Graziano, Claudio C; Capelli, Irene I; Minardi, Raffaella R; Aiello, Valeria V; Ambrosini, Enrico E; Cristalli, Carlotta Pia CP; Mattiaccio, Alessandro A; Pariali, Milena M; De Fanti, Sara S; Faletra, Flavio F; Grosso, Enrico E; Cantone, Rachele R; Mancini, Elena E; Mencarelli, Francesca F; Pasini, Andrea A; Wischmeijer, Anita A; Sciascia, Nicola N; Seri, Marco M; La Manna, Gaetano G
Publication Date: 2020

Variant appearance in text: PKD1: Arg3277Cys
PubMed Link: 32457805
Variant Present in the following documents:
  • Main text
  • fgene-11-00464.pdf
View BVdb publication page



Role of chemokines, innate and adaptive immunity.

Cellular Signalling
Zimmerman, Kurt A KA; Hopp, Katharina K; Mrug, Michal M
Publication Date: 2020-09

Variant appearance in text: PKD1: R3277C
PubMed Link: 32325183
Variant Present in the following documents:
  • Main text
View BVdb publication page



Beyond a Passive Conduit: Implications of Lymphatic Biology for Kidney Diseases.

Journal Of The American Society Of Nephrology : Jasn
Jafree, Daniyal J DJ; Long, David A DA
Publication Date: 2020-06

Variant appearance in text: PKD1: R3277C
PubMed Link: 32295825
Variant Present in the following documents:
  • Main text
View BVdb publication page



Regulation of polycystin expression, maturation and trafficking.

Cellular Signalling
Hu, Jinghua J; Harris, Peter C PC
Publication Date: 2020-08

Variant appearance in text: PKD1: Arg3277Cys
PubMed Link: 32275942
Variant Present in the following documents:
  • Main text
View BVdb publication page



Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.

Jci Insight
Kashyap, Sonu S; Hein, Kyaw Zaw KZ; Chini, Claudia Cs CC; Lika, Jorgo J; Warner, Gina M GM; Bale, Laurie K LK; Torres, Vicente E VE; Harris, Peter C PC; Oxvig, Claus C; Conover, Cheryl A CA; Chini, Eduardo N EN
Publication Date: 2020-02-27

Variant appearance in text: PKD1: R3277C
PubMed Link: 31990681
Variant Present in the following documents:
  • Main text
View BVdb publication page



Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations.

Journal Of Clinical Medicine
Kataoka, Hiroshi H; Fukuoka, Hinata H; Makabe, Shiho S; Yoshida, Rie R; Teraoka, Atsuko A; Ushio, Yusuke Y; Akihisa, Taro T; Manabe, Shun S; Sato, Masayo M; Mitobe, Michihiro M; Tsuchiya, Ken K; Nitta, Kosaku K; Mochizuki, Toshio T
Publication Date: 2020-01-05

Variant appearance in text: PKD1: R3277C
PubMed Link: 31948117
Variant Present in the following documents:
  • Main text
  • jcm-09-00146.pdf
View BVdb publication page



The consequences of increased 4E-BP1 in polycystic kidney disease.

Human Molecular Genetics
Holditch, Sara J SJ; Brown, Carolyn N CN; Atwood, Daniel J DJ; Pokhrel, Deepak D; Brown, Sara E SE; Lombardi, Andrew M AM; Nguyen, Khoa N KN; Hill, Ryan C RC; Lanaspa, Miguel M; Hopp, Katharina K; Weiser-Evans, Mary C M MCM; Edelstein, Charles L CL
Publication Date: 2019-12-15

Variant appearance in text: PKD1: R3277C
PubMed Link: 31646342
Variant Present in the following documents:
  • Main text
View BVdb publication page



Knockout of P2rx7 purinergic receptor attenuates cyst growth in a rat model of ARPKD.

American Journal Of Physiology. Renal Physiology
Arkhipov, Sergey N SN; Potter, D'Anna L DL; Geurts, Aron M AM; Pavlov, Tengis S TS
Publication Date: 2019-12-01

Variant appearance in text: PKD1: R3277C
PubMed Link: 31630543
Variant Present in the following documents:
  • Main text
View BVdb publication page



Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes.

Plos Genetics
Capalbo, Antonio A; Valero, Roberto Alonso RA; Jimenez-Almazan, Jorge J; Pardo, Pere Mir PM; Fabiani, Marco M; Jiménez, David D; Simon, Carlos C; Rodriguez, Julio Martin JM
Publication Date: 2019-10

Variant appearance in text: PKD1: 9829C>T; Arg3277Cys; rs148812376
PubMed Link: 31589614
Variant Present in the following documents:
  • pgen.1008409.s001.xlsx, sheet 1
View BVdb publication page



Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Journal Of The American Society Of Nephrology : Jasn
Olson, Rory J RJ; Hopp, Katharina K; Wells, Harrison H; Smith, Jessica M JM; Furtado, Jessica J; Constans, Megan M MM; Escobar, Diana L DL; Geurts, Aron M AM; Torres, Vicente E VE; Harris, Peter C PC
Publication Date: 2019-11

Variant appearance in text: PKD1: Arg3277Cys
PubMed Link: 31427367
Variant Present in the following documents:
  • Main text
View BVdb publication page



Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.

Scientific Reports
Yheskel, Matanel M; Lakhia, Ronak R; Cobo-Stark, Patricia P; Flaten, Andrea A; Patel, Vishal V
Publication Date: 2019-02-13

Variant appearance in text: PKD1: R3277C
PubMed Link: 30760828
Variant Present in the following documents:
  • Main text
  • 41598_2019_Article_38566.pdf
View BVdb publication page



Autosomal Dominant Polycystic Kidney Disease: Presence of Hypomorphic Alleles in PKD1 Gene.

Indian Journal Of Nephrology
Pandita, S S; Khullar, D D; Saxena, R R; Verma, I C IC
Publication Date: 2018

Variant appearance in text: PKD1: Arg3277Cys
PubMed Link: 30647506
Variant Present in the following documents:
  • Main text
View BVdb publication page



Polycystic kidney disease.

Nature Reviews. Disease Primers
Bergmann, Carsten C; Guay-Woodford, Lisa M LM; Harris, Peter C PC; Horie, Shigeo S; Peters, Dorien J M DJM; Torres, Vicente E VE
Publication Date: 2018-12-06

Variant appearance in text: PKD1: R3277C
PubMed Link: 30523303
Variant Present in the following documents:
  • Main text
View BVdb publication page



CD8+ T cells modulate autosomal dominant polycystic kidney disease progression.

Kidney International
Kleczko, Emily K EK; Marsh, Kenneth H KH; Tyler, Logan C LC; Furgeson, Seth B SB; Bullock, Bonnie L BL; Altmann, Christopher J CJ; Miyazaki, Makoto M; Gitomer, Berenice Y BY; Harris, Peter C PC; Weiser-Evans, Mary C M MCM; Chonchol, Michel B MB; Clambey, Eric T ET; Nemenoff, Raphael A RA; Hopp, Katharina K
Publication Date: 2018-12

Variant appearance in text: PKD1: R3277C
PubMed Link: 30249452
Variant Present in the following documents:
  • Main text
  • nihms-997941.pdf
View BVdb publication page



Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.

Journal Of The American Society Of Nephrology : Jasn
Lanktree, Matthew B MB; Haghighi, Amirreza A; Guiard, Elsa E; Iliuta, Ioan-Andrei IA; Song, Xuewen X; Harris, Peter C PC; Paterson, Andrew D AD; Pei, York Y
Publication Date: 2018-10

Variant appearance in text: PKD1: R3277C
PubMed Link: 30135240
Variant Present in the following documents:
  • Main text
View BVdb publication page



Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease.

Scientific Reports
Idowu, Jessica J; Home, Trisha T; Patel, Nisha N; Magenheimer, Brenda B; Tran, Pamela V PV; Maser, Robin L RL; Ward, Christopher J CJ; Calvet, James P JP; Wallace, Darren P DP; Sharma, Madhulika M
Publication Date: 2018-02-20

Variant appearance in text: PKD1: R3277C
PubMed Link: 29463793
Variant Present in the following documents:
  • Main text
  • 41598_2018_Article_21132.pdf
View BVdb publication page



Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Journal Of The American Society Of Nephrology : Jasn
Cornec-Le Gall, Emilie E; Torres, Vicente E VE; Harris, Peter C PC
Publication Date: 2018-01

Variant appearance in text: PKD1: 9829C>T; Arg3277Cys
PubMed Link: 29038287
Variant Present in the following documents:
  • Main text
View BVdb publication page



Rare diseases, rare presentations: recognizing atypical inherited kidney disease phenotypes in the age of genomics.

Clinical Kidney Journal
Ars, Elisabet E; Torra, Roser R
Publication Date: 2017-10

Variant appearance in text: PKD1: Arg3277Cys
PubMed Link: 28980669
Variant Present in the following documents:
  • Main text
  • sfx051.pdf
View BVdb publication page



PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.

American Journal Of Physiology. Renal Physiology
Lakhia, Ronak R; Yheskel, Matanel M; Flaten, Andrea A; Quittner-Strom, Ezekiel B EB; Holland, William L WL; Patel, Vishal V
Publication Date: 2018-01-01

Variant appearance in text: PKD1: R3277C
PubMed Link: 28903946
Variant Present in the following documents:
  • Main text
View BVdb publication page



microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.

Nature Communications
Hajarnis, Sachin S; Lakhia, Ronak R; Yheskel, Matanel M; Williams, Darren D; Sorourian, Mehran M; Liu, Xueqing X; Aboudehen, Karam K; Zhang, Shanrong S; Kersjes, Kara K; Galasso, Ryan R; Li, Jian J; Kaimal, Vivek V; Lockton, Steven S; Davis, Scott S; Flaten, Andrea A; Johnson, Joshua A JA; Holland, William L WL; Kusminski, Christine M CM; Scherer, Philipp E PE; Harris, Peter C PC; Trudel, Marie M; Wallace, Darren P DP; Igarashi, Peter P; Lee, Edmund C EC; Androsavich, John R JR; Patel, Vishal V
Publication Date: 2017-02-16

Variant appearance in text: PKD1: R3277C
PubMed Link: 28205547
Variant Present in the following documents:
  • Main text
  • ncomms14395.pdf
View BVdb publication page



Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.

Pediatric Nephrology (Berlin, Germany)
Gilbert, Rodney D RD; Evans, Hazel H; Olalekan, Kazeem K; Nagra, Arvind A; Haq, Mushfequr R MR; Griffiths, Mark M
Publication Date: 2017-05

Variant appearance in text: PKD1: 9829C>T
PubMed Link: 28194574
Variant Present in the following documents:
  • Main text
View BVdb publication page